Gaitskell K, Hermon C, Barnes I, Pirie K, Floud S, Green J, et al
Patients lose weight but often lose muscle, energy, and metabolic resilience along the way
Research into synthetic analogs of these hormones peptides that mimic or enhance their effects has become one of the most active areas of biomedical investigation
And the extended titration approach, maintaining each step for six weeks instead of four, dramatically improves tolerability for sensitive individuals
Higher average weight loss in published trials
Studies of metformin, DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 RAs, and pioglitazone in individuals who have undergone solid organ transplantation have demonstrated effectiveness and safety but are limited by small sample sizes, short follow-up, and risk of bias due to retrospective, single-center, or single-arm prospective designs (287)